Catalyst Wire Dossier Catalyst Wire Dossier

Cefotaxime and sulbactam sodium for injection (2:1)

· Xiangbei Welman Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cefotaxime and sulbactam sodium for injection (2:1), covering 2019-10-04 to 2019-10-04. Get the full timeline:

Most recent: Clinical Trial Update: Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection

See pricing